• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过去除与天冬酰胺连接的寡糖中的岩藻糖,增强源自肿瘤坏死因子受体II和淋巴细胞功能相关抗原3的Fc融合蛋白的Fc依赖性细胞毒性。

Enhanced Fc-dependent cellular cytotoxicity of Fc fusion proteins derived from TNF receptor II and LFA-3 by fucose removal from Asn-linked oligosaccharides.

作者信息

Shoji-Hosaka Emi, Kobayashi Yukari, Wakitani Masako, Uchida Kazuhisa, Niwa Rinpei, Nakamura Kazuyasu, Shitara Kenya

机构信息

Department of Antibody Research, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd., Machida-shi, Tokyo 194-8533.

出版信息

J Biochem. 2006 Dec;140(6):777-83. doi: 10.1093/jb/mvj207. Epub 2006 Oct 12.

DOI:10.1093/jb/mvj207
PMID:17038352
Abstract

Fucose removal from complex-type oligosaccharide of human IgGs results in a major enhancement of Fc-dependent cellular cytotoxicity. The aim of this study was to determine the effect of fucose removal on the effector function of another class of clinically important molecules that can effect cellular cytotoxicity, Fc fusion proteins. The receptors chosen for study were TNF receptor II and LFA-3, both of which have therapeutic significance. The fucosylated versions of these fusion proteins were produced in unmodified CHO cells, whereas the nonfucosylated counterparts were produced in CHO cells with alpha-1,6-fucosyltransferase, an enzyme required for fucosylation, knocked-out. Whilst binding activity of TNFRII-Fc and LFA-3-Fc were unchanged by fucose-removal, nonfucosylated Fc fusion proteins exhibited significantly higher Fc receptor gammaIIIa-binding and increased Fc-mediated cytotoxicity on target cells compared to fucosylated counterparts. Notably, in case of TNFRII-Fc, only the nonfucosylated protein exhibited potent Fc dependent cytotoxicity to transmembrane TNF-alpha expressing cells. These results prove that enhancement of Fc dependent cellular cytotoxicity by fucose-removal is effective in not only whole IgG but also Fc fusion proteins, and thus widens the potential of Fc-fusion proteins as therapeutic candidates.

摘要

从人免疫球蛋白的复合型寡糖中去除岩藻糖可显著增强Fc依赖性细胞毒性。本研究的目的是确定去除岩藻糖对另一类可影响细胞毒性的临床重要分子——Fc融合蛋白的效应器功能的影响。选择用于研究的受体是肿瘤坏死因子受体II(TNF receptor II)和淋巴细胞功能相关抗原3(LFA-3),二者均具有治疗意义。这些融合蛋白的岩藻糖基化版本在未修饰的中国仓鼠卵巢细胞(CHO细胞)中产生,而非岩藻糖基化的对应物则在敲除了岩藻糖基化所需的α-1,6-岩藻糖基转移酶的CHO细胞中产生。虽然去除岩藻糖并未改变TNFRII-Fc和LFA-3-Fc的结合活性,但与岩藻糖基化的对应物相比,非岩藻糖基化的Fc融合蛋白表现出显著更高的Fc受体γIIIa结合能力,并增强了对靶细胞的Fc介导的细胞毒性。值得注意的是,就TNFRII-Fc而言,只有非岩藻糖基化蛋白对表达跨膜TNF-α的细胞表现出强大的Fc依赖性细胞毒性。这些结果证明,去除岩藻糖增强Fc依赖性细胞毒性不仅对完整的免疫球蛋白有效,对Fc融合蛋白也有效,从而拓宽了Fc融合蛋白作为治疗候选药物的潜力。

相似文献

1
Enhanced Fc-dependent cellular cytotoxicity of Fc fusion proteins derived from TNF receptor II and LFA-3 by fucose removal from Asn-linked oligosaccharides.通过去除与天冬酰胺连接的寡糖中的岩藻糖,增强源自肿瘤坏死因子受体II和淋巴细胞功能相关抗原3的Fc融合蛋白的Fc依赖性细胞毒性。
J Biochem. 2006 Dec;140(6):777-83. doi: 10.1093/jb/mvj207. Epub 2006 Oct 12.
2
Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region.从复合型寡糖中去除岩藻糖可增强单基因编码抗体的抗体依赖性细胞毒性,该单基因编码抗体由连接抗体恒定区的单链抗体组成。
J Immunol Methods. 2005 Nov 30;306(1-2):93-103. doi: 10.1016/j.jim.2005.07.025. Epub 2005 Oct 3.
3
IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides.通过去除与天冬酰胺297相连的寡糖中的岩藻糖,实现与IgG亚类无关的抗体依赖性细胞毒性改善。
J Immunol Methods. 2005 Nov 30;306(1-2):151-60. doi: 10.1016/j.jim.2005.08.009. Epub 2005 Sep 22.
4
Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded bispecific antibody comprising of two single-chain antibodies linked to the antibody constant region.从复合型寡糖中去除岩藻糖可增强单基因编码双特异性抗体的抗体依赖性细胞毒性,该双特异性抗体由与抗体恒定区相连的两个单链抗体组成。
J Biochem. 2006 Sep;140(3):359-68. doi: 10.1093/jb/mvj157. Epub 2006 Jul 21.
5
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.具有三种不同N-连接Fc寡糖(高甘露糖型、杂合型和复合型)的非岩藻糖基化治疗性IgG1抗体之间的生物学活性比较。
Glycobiology. 2007 Jan;17(1):104-18. doi: 10.1093/glycob/cwl057. Epub 2006 Sep 29.
6
The N-linked oligosaccharide at Fc gamma RIIIa Asn-45: an inhibitory element for high Fc gamma RIIIa binding affinity to IgG glycoforms lacking core fucosylation.FcγRIIIa 天冬酰胺-45 位点的 N 连接寡糖:对缺乏核心岩藻糖基化的 IgG 糖型具有高 FcγRIIIa 结合亲和力的抑制元件。
Glycobiology. 2009 Feb;19(2):126-34. doi: 10.1093/glycob/cwn110. Epub 2008 Oct 24.
7
Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.Fc 蛋白和 Fc 糖基工程联合修饰 scFv-Fc 融合蛋白可协同增强 CD16a 结合,但不能进一步增强 NK 细胞介导的 ADCC。
J Immunol Methods. 2011 Oct 28;373(1-2):67-78. doi: 10.1016/j.jim.2011.08.003. Epub 2011 Aug 9.
8
Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1.人免疫球蛋白G1岩藻糖基化和非岩藻糖基化Fc片段的结构比较
J Mol Biol. 2007 May 4;368(3):767-79. doi: 10.1016/j.jmb.2007.02.034. Epub 2007 Feb 22.
9
A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients.一种非岩藻糖基化的抗HER2抗体可增强乳腺癌患者的抗体依赖性细胞毒性。
Clin Cancer Res. 2007 Mar 15;13(6):1875-82. doi: 10.1158/1078-0432.CCR-06-1335.
10
Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors.抗体Fc第296位侧链在与FcγRIIIa及其他Fcγ受体相互作用中的重要性
PLoS One. 2015 Oct 7;10(10):e0140120. doi: 10.1371/journal.pone.0140120. eCollection 2015.

引用本文的文献

1
Treatment of Parkinson's disease with biologics that penetrate the blood-brain barrier via receptor-mediated transport.使用通过受体介导转运穿透血脑屏障的生物制剂治疗帕金森病。
Front Aging Neurosci. 2023 Nov 13;15:1276376. doi: 10.3389/fnagi.2023.1276376. eCollection 2023.
2
Engineering protein-based therapeutics through structural and chemical design.通过结构和化学设计工程蛋白质类治疗药物。
Nat Commun. 2023 Apr 27;14(1):2411. doi: 10.1038/s41467-023-38039-x.
3
A Historical Review of Brain Drug Delivery.脑药物递送的历史回顾
Pharmaceutics. 2022 Jun 16;14(6):1283. doi: 10.3390/pharmaceutics14061283.
4
Profiling of N-Linked Oligosaccharides of a Glycoprotein by UPLC-FLR-ESI-MS After Derivatization with Fluorescent Anthranilamide.利用荧光苯二胺衍生化后通过 UPLC-FLR-ESI-MS 对糖蛋白的 N-连接寡糖进行分析。
Methods Mol Biol. 2021;2271:179-188. doi: 10.1007/978-1-0716-1241-5_13.
5
Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity.针对人白细胞介素 5 受体α亚基的人源化抗体的工程改造,导致了有效的抗体依赖性细胞介导的细胞毒性。
Front Immunol. 2021 Jan 8;11:593748. doi: 10.3389/fimmu.2020.593748. eCollection 2020.
6
A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis.一种通过毛细管电泳对IgG Fc和Fab糖基化进行高通量、灵敏分析的方法。
J Immunol Methods. 2015 Feb;417:34-44. doi: 10.1016/j.jim.2014.12.004. Epub 2014 Dec 15.
7
Fc-fusion proteins: new developments and future perspectives.Fc 融合蛋白:新进展与未来展望。
EMBO Mol Med. 2012 Oct;4(10):1015-28. doi: 10.1002/emmm.201201379. Epub 2012 Jul 26.
8
Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activities.定量评价人源化抗体对 Fcγ 受体结合和抗体依赖的细胞介导的细胞毒性活性中岩藻糖的降低作用。
MAbs. 2012 May-Jun;4(3):326-40. doi: 10.4161/mabs.19941. Epub 2012 Apr 26.
9
Neuroprotection with a brain-penetrating biologic tumor necrosis factor inhibitor.穿透血脑屏障的生物肿瘤坏死因子抑制剂的神经保护作用。
J Pharmacol Exp Ther. 2011 Nov;339(2):618-23. doi: 10.1124/jpet.111.185876. Epub 2011 Aug 10.
10
Production of therapeutic antibodies with controlled fucosylation.具有可控岩藻糖基化的治疗性抗体的生产。
MAbs. 2009 May-Jun;1(3):230-6. doi: 10.4161/mabs.1.3.8328. Epub 2009 May 28.